Literature DB >> 8717533

Effects of altered diet on serum levels of 1,25-dihydroxyvitamin D and parathyroid hormone in X-linked hypophosphatemic (Hyp and Gy) mice.

R A Meyer1, M H Meyer, P L Morgan.   

Abstract

X-linked hypophosphatemia is a metabolic bone disease occurring in both humans and mice. In mice, two different mutations (Hyp and Gy), occurring at separate but closely linked loci, have been proposed as models for this disease. Varying reports of the Vitamin D status of these two mutants has led us to reexamine the influence of diet on circulating calcitrophic hormones and mineral metabolism in both mutants. Hyp and Gy mice were raised on the B6C3H background, and both normal females and heterozygous mutant females were studied at 10 weeks of age. Animals were fed one of three diets at random: high (1.5% Ca and 1.0% P); medium (0.6% Ca and 0.6% P); or low (0.0% Ca and 0.6% P). After 3 days, serum and urine samples were collected. In comparison to mutant mice fed the high diet, both Hyp and Gy mice fed the low diet had decreased serum calcium levels, and further elevations in both serum alkaline phosphatase and serum parathyroid hormone (PTH). Serum 1,25-dihydroxyvitamin D levels were elevated by both the medium and low diets in all groups of mice over values obtained with the high diet. Mutant mice were significantly higher in serum PTH on all diets compared to normal mice fed the same diet. Mutant mice were not elevated in serum 1,25-dihydroxyvitamin D over normal mice when fed the high diet. However, both Hyp and Gy mice fed the medium and low diets were elevated in serum 1,25-dihydroxyvitamin D over normal mice. Serum PTH levels were correlated to serum 1,25-dihydroxyvitamin D levels with Hyp and Gy mice lying on the same line (r = 0.86; p < 0.0001). In summary, when Hyp and Gy mice are studied on the same genetic background and fed the same diet, similar responses are seen in PTH levels and 1,25-dihydroxyvitamin D levels. Both mutants should be useful in elucidating the pathophysiology of this poorly understood human disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8717533     DOI: 10.1016/8756-3282(95)00420-3

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

1.  1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.

Authors:  Eva S Liu; Janaina S Martins; Adalbert Raimann; Byongsoo Timothy Chae; Daniel J Brooks; Vanda Jorgetti; Mary L Bouxsein; Marie B Demay
Journal:  J Bone Miner Res       Date:  2016-02-02       Impact factor: 6.741

2.  Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.

Authors:  Danielle Tokarz; Janaina S Martins; Elizabeth T Petit; Charles P Lin; Marie B Demay; Eva S Liu
Journal:  J Bone Miner Res       Date:  2017-11-17       Impact factor: 6.741

3.  Effects of Active Vitamin D or FGF23 Antibody on Hyp Mice Dentoalveolar Tissues.

Authors:  E J Lira Dos Santos; M B Chavez; M H Tan; F F Mohamed; T N Kolli; B L Foster; E S Liu
Journal:  J Dent Res       Date:  2021-04-27       Impact factor: 6.116

4.  Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice.

Authors:  Xiaofang Wang; Suzhen Wang; Changcheng Li; Tian Gao; Ying Liu; Afsaneh Rangiani; Yao Sun; Jianjun Hao; Anne George; Yongbo Lu; Jay Groppe; Baozhi Yuan; Jian Q Feng; Chunlin Qin
Journal:  PLoS Genet       Date:  2012-05-17       Impact factor: 5.917

5.  A novel Mixture Model Method for identification of differentially expressed genes from DNA microarray data.

Authors:  Kayvan Najarian; Maryam Zaheri; Ali A Rad; Siamak Najarian; Javad Dargahi
Journal:  BMC Bioinformatics       Date:  2004-12-16       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.